114284-26-3

Upstream product

• 126120-73-8 4-(4-methoxy-phenyl)-1-methyl-piperidin-4-ol 
• 1445-73-4 1-Methyl-4-piperidone 
• 100-66-3 methoxybenzene 
• 13139-86-1 4-methoxyphenyl magnesium bromide 
• 14774-77-7 p-methoxyphenyllithium 

Downstream Products

• 326812-68-4 4-(1-methylpiperidin-4-yl)phenol 
• 740789-86-0 N-methyl-4-(4-methoxyphenyl)piperidine 
• 872057-24-4 1-(2-methoxy-5-(1-methylpiperidin-4-yl)phenyl)ethanone 

Relevant academic research and scientific papers

Antiproliferative properties of piperidinylchalcones

Methoxylated chalcones bearing N-methylpiperidinyl substituents on ring A inhibited the growth of human tumour cell lines (MCF, HCT 116, and Jurkat) at IC50 values of 50 of 12. Down regulation of cell cycle regulatory components (CDK4, cyclin B, E2F, and phosphorylated Rb) were observed under similar conditions. Methoxylated chalcones without the piperidinyl substituent were found to exert equally potent and selective antiproliferative activity against HCT 116 tumour cells but did not interfere with cell cycle progression at their IC50 concentrations. The presence of the piperidinyl substituent in the chalcone template is proposed to lend specificity to the mechanism of antiproliferative activity, in addition to promoting a more desirable physicochemical profile.

Assessment of structural requirements for the monoamine oxidase-B- catalyzed oxidation of 1,4-disubstituted-1,2,3,6-tetrahydropyridine derivatives related to the neurotoxin 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine

The monoamine oxidase B (MAO-B) substrate properties and distance measurements along the N1-C4 axis of 38 1,4-disubstituted-1,2,3,6- tetrahydropyridine derivatives, including seven newly synthesized MPTP analogs, were used to define